Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate

P. L. Roberts, C. Dunkerley
  • Vox Sanguinis, April 2003, Wiley
  • DOI: 10.1046/j.1423-0410.2003.00275.x
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Peter L Roberts

In partnership with: